Hernberg, M <br/><br/>
Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Sep 1999 
 - 145-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1357-0560 
<br/><br/><label>Standard No.: </label>10.1007/BF02906126  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>CD4-CD8 Ratio--drug effects<br/>Carcinoma, Renal Cell--immunology<br/>Humans<br/>Immunity, Cellular<br/>Immunotherapy<br/>Kidney Neoplasms--immunology<br/>Killer Cells, Natural--drug effects<br/>Lymphocyte Subsets--drug effects<br/>Melanoma--immunology<br/>Neoplasms--immunology<br/>Prognosis